We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




RF Ablation Catheter Treats Cardiac Arrhythmia

By HospiMedica International staff writers
Posted on 03 Feb 2014
An innovative open irrigated ablation catheter treats atrial flutter by destroying sections of cardiac tissue responsible for the arrhythmias.

The Therapy Cool Flex ablation catheter is a steerable, deflectable, irrigated catheter used to treat atrial flutter by finding the source of the rhythm disturbance in focal areas of tissue located in the atria of the heart. More...
The ablation catheter is powered by a proprietary cardiac ablation generator that delivers radiofrequency (RF) energy to the laser-cut tip that is designed with a specially cut pattern that allows the catheter tip to be flexible, and provides a more uniform distribution of saline fluid.

The unique, laser-cut catheter tip electrode features irrigation slits arranged in a zigzag pattern to allow saline to flow around the entire surface area of the tip, improving cooling performance. The four ports on the distal tip enhance cooling when the catheter is in a perpendicular orientation, but once the tip is flexed, the laser-cut tip opens further on one side, directing up to 70% of the irrigation flow toward the tip-to-tissue interface. Average tip temperature is approximately 5 °C cooler in comparison to rigid tip catheters, with the possibility of reduced thrombus, char formation, and steam pops.

The device is inserted percutaneously and is manually advanced until it reaches the correct location inside the atrium. The tip of the catheter can be deformed by pushing or pulling on the handle, facilitating navigation. Once inside the heart, electrodes at the tip of the catheter identify the ablation site by electrical mapping. Once identified, RF energy destroys the tissues responsible for the flutter. The catheter is removed after treatment. The Therapy Cool Flex ablation catheter is a product of Irvine Biomedical, a St. Jude Medical (Irvine, CA, USA) company, and has been approved by the US Food and Drug Administration (FDA).

Related Links:

St. Jude Medical



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Warming Cabinet
EC1850BL
New
Powered Surgical Stapler
ECHELON 3000 Stapler
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The principle of needle-free injection based on the reflection of shock waves through microbubble dynamics (Photo courtesy of Yibo Ma/Kyushu University)

Novel Needle-Free Reagent Injection Method to Reduce Spread of Infectious Diseases

Currently, drug administration for disease treatment and prevention commonly uses injectors with metal needles. However, as the needle directly contacts the patient’s mucus and blood, the use of different... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.